Arcellx Inc (ACLX)

Nov 24, 2025

Arcellx sinks following results from Kelonia CAR-T therapy for multiple myeloma - Seeking Alpha

Nov 24, 2025

Nov 24, 2025

Guggenheim reiterates Buy rating on Arcellx stock, says weakness overdone - Investing.com India

Nov 24, 2025

Nov 24, 2025

Citi says Arcellx weakness on ‘highly preliminary’ Kelonia data an overreaction - TipRanks

Nov 24, 2025

Nov 24, 2025

Why Arcellx Inc Shares Took a Hit Today - TipRanks

Nov 24, 2025

Nov 24, 2025

Arcellx stock falls after Kelonia reveals promising blood cancer data By Investing.com - Investing.com Canada

Nov 24, 2025

Nov 24, 2025

Arcellx weakness on competitive worries ‘overdone,’ says Guggenheim - TipRanks

Nov 24, 2025

Nov 24, 2025

First Week of January 2026 Options Trading For Arcellx (ACLX) - Nasdaq

Nov 24, 2025

Nov 21, 2025

Can Arcellx Inc. stock withstand economic slowdownEarnings Beat & Proven Capital Preservation Methods - newser.com

Nov 21, 2025

Nov 20, 2025

Arcellx Inc’s Strategic Advantage in Gilead Partnership Drives Buy Rating and $130 Price Target - TipRanks

Nov 20, 2025

Nov 19, 2025

Risk vs reward if holding onto Arcellx Inc.Weekly Risk Report & Entry Point Confirmation Signals - newser.com

Nov 19, 2025

Nov 19, 2025

What institutional flow reveals about Arcellx Inc.Watch List & Fast Entry Momentum Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Tools to assess Arcellx Inc.’s risk profileWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Arcellx Inc. stock performs during Fed tightening cyclesPrice Action & AI Forecasted Entry/Exit Points - newser.com

Nov 19, 2025

Nov 19, 2025

Is Arcellx Inc. stock a dividend growth opportunityQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com

Nov 19, 2025

Nov 18, 2025

Why Arcellx Inc. is moving today2025 Price Targets & Daily Market Momentum Tracking - newser.com

Nov 18, 2025

Nov 18, 2025

Wolfe Research Initiates Coverage of Arcellx (ACLX) with Peer Perform Recommendation - Nasdaq

Nov 18, 2025

Nov 18, 2025

Arcellx (NASDAQ: ACLX) plans ASH event on Phase 2 iMMagine-1 myeloma trial data - Stock Titan

Nov 18, 2025

Nov 17, 2025

Arcellx CMO Heery sells $30,600 in ACLX stock By Investing.com - Investing.com South Africa

Nov 17, 2025

Nov 17, 2025

Arcellx CMO Heery sells $30,600 in ACLX stock - Investing.com India

Nov 17, 2025

Nov 17, 2025

Arcellx stock initiated at Peerperform by Wolfe Research amid BCMA market competition - Investing.com Nigeria

Nov 17, 2025

Nov 17, 2025

Arcellx initiated with a Peer Perform at Wolfe Research - TipRanks

Nov 17, 2025

Nov 16, 2025

Can technical indicators confirm Arcellx Inc.’s reversalGlobal Markets & High Return Stock Watch Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Will Arcellx Inc. stock split again soonJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Trend analysis for Arcellx Inc. this weekSwing Trade & Community Trade Idea Sharing - newser.com

Nov 16, 2025

Nov 15, 2025

Price-Driven Insight from (ACLX) for Rule-Based Strategy - news.stocktradersdaily.com

Nov 15, 2025

Nov 14, 2025

Using Python tools to backtest Arcellx Inc. strategiesWatch List & Stepwise Entry and Exit Trade Signals - newser.com

Nov 14, 2025

Nov 13, 2025

Arcellx Inc.: Promising Developments and Strategic Positioning Drive Buy Rating - TipRanks

Nov 13, 2025